Getting molnupiravir to patients in a timely way is likely to be problematic

BMJ. 2021 Nov 2:375:n2648. doi: 10.1136/bmj.n2648.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents* / therapeutic use
  • COVID-19*
  • Humans

Substances

  • Antiviral Agents